New pill cocktail could boost liver cancer treatment
NCT ID NCT07309419
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 22 times
Summary
This study compares two treatments for people with liver cancer that cannot be removed by surgery. One group gets a standard procedure (TACE) plus a three-drug pill regimen, while the other gets TACE plus standard targeted therapy and immunotherapy. The goal is to see which combination helps people live longer. About 222 adults who have not had prior liver cancer treatment will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.